WAYNE, Pa.--(BUSINESS WIRE)--Sep. 12, 2014--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care, urology and surgery, will showcase its Arrow®
brand interventional radiology portfolio at the Annual Meeting of the
Cardiovascular and Interventional Radiological Society of Europe (CIRSE)
to be held in Glasgow, Scotland on September 13-17, 2014.
During the event, the Company will highlight both the Arrow® GPSCath™
Balloon Dilatation Catheter featuring innovative VisioValve™ technology
over a 0.014 guidewire - now for BTK (below the knee), and the Arrow
OnControl® Powered Bone Access System. In addition, the Company will
also present highly kink-resistant sheath introducers, dialysis access
products and angiographic diagnostic catheters.
The GPSCath™ Catheter is a specialty two-in-one device that is intended
for BTK allowing the physician to conduct angioplasty and inject fluid
[targeted angiogram specifically at lesion site] while maintaining
catheter and guidewire position. Below-the-knee interventions can be
complex undertakings, requiring multiple devices, numerous procedural
steps and significant procedural time. Arrow now offers a solution by
combining multiple required features into one device.
The Arrow OnControl Powered Bone Access System offers the ability to
effectively, safely and rapidly obtain superior bone samples. Our bone
lesion biopsy needle is designed specifically for multiple bone biopsies
from a single cortical penetration. Using Teleflex’s patented
technology, the Arrow OnControl Powered Bone Access System provides
interventional radiologists a faster, more reliable solution for
accessing dense and hard-to-reach bone lesions.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Wayne, PA,
Teleflex employs approximately 11,500 people worldwide and serves
healthcare providers in more than 150 countries. Additional information
about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, Arrow, GPSCath, VisioValve and OnControl are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates. © 2014
Teleflex Incorporated. All rights reserved.
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com
or
Martina
Teichmann-Zindler
Director Marketing Communications International
+49
(0)7151-406-538
martina.teichmann@teleflex.com
www.teleflex.com